Neal Edward Ready | Scholars@Duke

Neal Edward Ready
Professor of Medicine

Current Appointments & Affiliations

Professor of Medicine, Medicine, Medical Oncology, Medicine 2016
Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2006

Contact Information

25178 Morris Bldg-200 Trent Dr., Box 3198, Durham, NC 27710
Duke Box 3198, Rm25178 Morris Bldg/ 200 Trent Dr., Durham, NC 27710
neal.ready@duke.edu (919) 681-6932

Background
Education, Training, & Certifications
- Fellow In Hematology Oncology, Medicine, Tufts University 1992 - 1994
- Fellow In Hematology Oncology, Medicine, Brown University 1990 - 1992
- Medical Resident, Medicine, Brown University 1986 - 1989
- M.D., Vanderbilt University 1986
- Ph.D., University of California at Irvine 1983
Duke Appointment History
- Associate Professor of Medicine, Medicine, Medical Oncology, Medicine 2014 - 2016
- Associate Professor of Medicine, Medicine, Medical Oncology, Medicine 2010 - 2014
- Assistant Professor of Medicine, Medicine, Medical Oncology, Medicine 2006 - 2010
- Instructor, Temporary in the Department of Medicine, Medicine, Medical Oncology, Medicine 2006
Research
Selected Grants
- AFT_31_ALLIANCE FOUNDATION TRIAL awarded by Alliance Foundation Trials, LLC 2017 - 2022
- BMS CA209817 awarded by Bristol-Myers Squibb Company 2017 - 2021
- TOP 1501 awarded by Merck 2016 - 2021
- BMS451 awarded by Bristol-Myers Squibb Company 2016 - 2021
- TRINITY awarded by Stem CentRx, Inc. 2016 - 2021
- CheckMate 568 awarded by Bristol-Myers Squibb Company 2016 - 2021
- BMS-227 awarded by Bristol-Myers Squibb Company 2015 - 2020
- Condor awarded by AstraZeneca LP 2015 - 2020
- BMS CA 209-331-001 An Open label, Randomized Phase 3 Study of Nivolumab or Chemo awarded by The Bristol-Myers/Sanofi Pharmaceuticals, Inc. Partnership 2015 - 2020
- A phase II, multi-center, single-arm, global study of MEDI4736 monotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) awarded by AstraZeneca Pharmaceuticals, LP 2015 - 2020
- A phase 1 / 2 multicenter study of BMS-986012 in subjects with relapsed/refractory small cell lung cnacer awarded by Bristol-Myers Squibb Company 2014 - 2019
- A Phase I study to evaluate the saftey, phamocokinetics and pharmacodynamics of JNJ-42756493 a pan-fibroblat growth fact awarded by Janssen Research & Development, LLC 2014 - 2019
- An open label, randomized phase 3 clincal trial of Nivolumab vs therapy of investigator's choice in recurrent or metasti awarded by Bristol-Myers Squibb Company 2014 - 2019
- A phase II, multicenter, single-arm study of MPDL3280A in patients with advanced PD-L1_positive Locally advanced or Meta awarded by Genentech, Inc. 2013 - 2018
- Phase I/II open label dose escalation study of the safety, pharmacokinetics, and preliminary efficacy of SCI6D6.5 as a s awarded by Stem CentRx, Inc. 2013 - 2018
- Evaluation of Tumor Infiltrating Lymphocytes in Resected Non Small Cell Lung Cancer awarded by Lung Cancer Initiative of North Carolina 2015 - 2018
- An open-label, randomized, phase 3 trial of Nivolumab vs Investigator's choice chemotherapy as first-line therapy ofr st awarded by Bristol-Myers Squibb Company 2014 - 2017
- Abbvie M14-361 awarded by AbbVie Inc. 2015 - 2017
- Programs in Clinical Effectiveness of Cancer Pharmacogenomics awarded by National Institutes of Health 2009 - 2012
- Refining and Validating Genomic Signatures in Lung Cancer awarded by National Institutes of Health 2009 - 2010
Publications & Artistic Works
Selected Publications
- Journal Articles
  - Tandberg, DJ, Kelsey, CR, D'Amico, TA, Crawford, J, Chino, JP, Tong, BC, Ready, NE, and Wright, A. "Patterns of Failure After Surgery for Non-Small-cell Lung Cancer Invading the Chest Wall." Clinical lung cancer 18, no. 4 (July 2017): e259-e265. Full Text
  - Zhou, F, Wang, Y, Liu, H, Ready, N, Han, Y, Hung, RJ, Brhane, Y, McLaughlin, J, Brennan, P, Bickeböller, H, Rosenberger, A, Houlston, RS, Caporaso, N, Landi, MT, Brüske, I, Risch, A, Ye, Y, Wu, X, Christiani, DC, Goodman, G, Chen, C, Transdisciplinary Research in Cancer of the Lung (TRICL) Research Team, , Amos, CI, and Wei, Q. "Susceptibility loci of CNOT6 in the general mRNA degradation pathway and lung cancer risk-A re-analysis of eight GWASs." Molecular carcinogenesis 56, no. 4 (April 2017): 1227-1238. Full Text
  - Kelley, MJ, Jha, G, Shoemaker, D, Herndon, JE, Gu, L, Barry, WT, Crawford, J, and Ready, N. "Phase II Study of Dasatinib in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer." Cancer investigation 35, no. 1 (January 2017): 32-35. Full Text
  - Rudin, CM, Pietanza, MC, Bauer, TM, Ready, N, Morgensztern, D, Glisson, BS, Byers, LA, Johnson, ML, Burris, HA, Robert, F, Han, TH, Bheddah, S, Theiss, N, Watson, S, Mathur, D, Vennapusa, B, Zayed, H, Lally, S, Strickland, DK, Govindan, R, Dylla, SJ, Peng, SL, Spigel, DR, and SCRX16-001 investigators, . "Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study." The Lancet. Oncology 18, no. 1 (January 2017): 42-51. Full Text
  - Ryser, MD, Lee, WT, Ready, NE, Leder, KZ, and Foo, J. "Quantifying the Dynamics of Field Cancerization in Tobacco-Related Head and Neck Cancer: A Multiscale Modeling Approach." Cancer research 76, no. 24 (December 2016): 7078-7088. Full Text
  - Boyer, MJ, Gu, L, Wang, X, Kelsey, CR, Yoo, DS, Onaitis, MW, Dunphy, FR, Crawford, J, Ready, NE, and Salama, JK. "Toxicity of definitive and post-operative radiation following ipilimumab in non-small cell lung cancer." Lung cancer (Amsterdam, Netherlands) 98 (August 2016): 76-78. Full Text
  - Wang, Y, Liu, H, Ready, NE, Su, L, Wei, Y, Christiani, DC, and Wei, Q. "Genetic variants in ABCG1 are associated with survival of nonsmall-cell lung cancer patients." International journal of cancer 138, no. 11 (June 2016): 2592-2601. Full Text
  - Kelsey, CR, Christensen, JD, Chino, JP, Adamson, J, Ready, NE, and Perez, BA. "Adaptive planning using positron emission tomography for locally advanced lung cancer: A feasibility study." Practical radiation oncology 6, no. 2 (March 2016): 96-104. Full Text
  - Salama, JK, Gu, L, Wang, X, Pang, HH, Bogart, JA, Crawford, J, Schild, SE, Vokes, EE, and Ready, NE. "Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE)." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 11, no. 3 (March 2016): 361-369. Full Text
  - Roe, MT, Cyr, DD, Eckart, D, Schulte, PJ, Morse, MA, Blackwell, KL, Ready, NE, Zafar, SY, Beaven, AW, Strickler, JH, Onken, JE, Winters, KJ, Houterloot, L, Zamoryakhin, D, Wiviott, SD, White, HD, Prabhakaran, D, Fox, KAA, Armstrong, PW, Ohman, EM, and TRILOGY ACS Investigators, . "Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome." European heart journal 37, no. 4 (January 2016): 412-422. Full Text
  - Clarke, JM, Wang, X, and Ready, NE. "Surrogate clinical endpoints to predict overall survival in non-small cell lung cancer trials-are we in a new era?." Translational lung cancer research 4, no. 6 (December 2015): 804-808. Full Text
  - Kelsey, CR, Das, S, Gu, L, Dunphy, FR, Ready, NE, and Marks, LB. "Phase 1 Dose Escalation Study of Accelerated Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Lung Cancer." International journal of radiation oncology, biology, physics 93, no. 5 (December 2015): 997-1004. Full Text
  - Borghaei, H, Paz-Ares, L, Horn, L, Spigel, DR, Steins, M, Ready, NE, Chow, LQ, Vokes, EE, Felip, E, Holgado, E, Barlesi, F, Kohlhäufl, M, Arrieta, O, Burgio, MA, Fayette, J, Lena, H, Poddubskaya, E, Gerber, DE, Gettinger, SN, Rudin, CM, Rizvi, N, Crinò, L, Blumenschein, GR, Antonia, SJ, Dorange, C, Harbison, CT, Graf Finckenstein, F, and Brahmer, JR. "Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer." The New England journal of medicine 373, no. 17 (October 2015): 1627-1639. Full Text
  - Brahmer, J, Reckamp, KL, Baas, P, Crinò, L, Eberhardt, WEE, Poddubskaya, E, Antonia, S, Pluzanski, A, Vokes, EE, Holgado, E, Waterhouse, D, Ready, N, Gainor, J, Arén Frontera, O, Havel, L, Steins, M, Garassino, MC, Aerts, JG, Domine, M, Paz-Ares, L, Reck, M, Baudelet, C, Harbison, CT, Lestini, B, and Spigel, DR. "Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer." The New England journal of medicine 373, no. 2 (July 2015): 123-135. Full Text
  - Ready, NE, Pang, HH, Gu, L, Otterson, GA, Thomas, SP, Miller, AA, Baggstrom, M, Masters, GA, Graziano, SL, Crawford, J, Bogart, J, and Vokes, EE. "Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance)." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 33, no. 15 (May 2015): 1660-1665. Full Text
  - Pepek, JM, Marks, LB, Berry, MF, Ready, NE, Gee, NG, Coleman, RE, D'Amico, TA, Crawford, J, and Kelsey, CR. "Accuracy of positron emission tomography in identifying hilar (N1) lymph node involvement in non-small cell lung cancer: Implications for stereotactic body radiation therapy." Practical radiation oncology 5, no. 2 (March 2015): 79-84. Full Text
  - Pepek, JM, Marks, LB, Berry, MF, Ready, NE, Gee, NG, Coleman, RE, D'Amico, TA, Crawford, J, and Kelsey, CR. "Accuracy of positron emission tomography in identifying hilar (N1) lymph node involvement in non-small cell lung cancer: Implications for stereotactic body radiation therapy." Practical Radiation Oncology 5, no. 2 (March 1, 2015): 79-84. Full Text
  - Boyle, JM, Tandberg, DJ, Chino, JP, D'Amico, TA, Ready, NE, and Kelsey, CR. "Smoking history predicts for increased risk of second primary lung cancer: a comprehensive analysis." Cancer 121, no. 4 (February 2015): 598-604. Full Text
  - Uronis, HE, Jia, J, Bendell, JC, Howard, L, Ready, NA, Lee, PH, Starr, MD, Dellinger, A, Pang, H, Nixon, AB, and Hurwitz, HI. "A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors." Cancer chemotherapy and pharmacology 75, no. 2 (February 2015): 343-352. Full Text
  - Uronis, HE, Jia, J, Bendell, JC, Howard, L, Ready, NA, Lee, PH, Starr, MD, Dellinger, A, Pang, H, Nixon, AB, and Hurwitz, HI. "A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors." Cancer Chemotherapy and Pharmacology 75, no. 2 (January 1, 2015): 343-352. Full Text
  - Stevenson, M, Christensen, J, Shoemaker, D, Foster, T, Barry, WT, Tong, BC, Wahidi, M, Shofer, S, Datto, M, Ginsburg, G, Crawford, J, D'Amico, T, and Ready, N. "Tumor acquisition for biomarker research in lung cancer." Cancer investigation 32, no. 6 (July 2014): 291-298. Full Text
  - Denehy, L, Hornsby, WE, Herndon, JE, Thomas, S, Ready, NE, Granger, CL, Valera, L, Kenjale, AA, Eves, ND, and Jones, LW. "Prognostic Validation of the Body Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity (BODE) Index in Inoperable Non-Small-Cell Lung Cancer." JOURNAL OF THORACIC ONCOLOGY 8, no. 12 (December 2013): 1545-1550. Full Text Link to Item
  - Tandberg, DJ, Gee, NG, Chino, JP, D'Amico, TA, Ready, NE, Coleman, RE, and Kelsey, CR. "Are discordant positron emission tomography and pathological assessments of the mediastinum in non-small cell lung cancer significant?." J Thorac Cardiovasc Surg 146, no. 4 (October 2013): 796-801. Full Text Link to Item
  - Washington, I, Chino, JP, Marks, LB, D'Amico, TA, Berry, MF, Ready, NE, Higgins, KA, Yoo, DS, and Kelsey, CR. "Diabetes mellitus: A significant co-morbidity in the setting of lung cancer?." THORACIC CANCER 4, no. 2 (May 2013): 123-130. Full Text Link to Item
  - Kalemkerian, GP, Akerley, W, Bogner, P, Borghaei, H, Chow, LQM, Downey, RJ, Gandhi, L, Ganti, AKP, Govindan, R, Grecula, JC, Hayman, J, Heist, RS, Horn, L, Jahan, T, Koczywas, M, Jr, BWL, Merritt, RE, Moran, CA, Niell, HB, O'Malley, J, Patel, JD, Ready, N, Rudin, CM, Jr, CCW, Gregory, K, and Hughes, M. "Small cell lung cancer: Clinical practice guidelines in oncology." JNCCN Journal of the National Comprehensive Cancer Network 11, no. 1 (2013): 78-98.
  - Tandberg, DJ, Gee, NG, Chino, JP, D'Amico, TA, Ready, NE, Coleman, RE, and Kelsey, CR. "Are discordant positron emission tomography and pathological assessments of the mediastinum in non-small cell lung cancer significant?." Journal of Thoracic and Cardiovascular Surgery 146, no. 4 (2013): 796-801. Full Text
  - Higgins, KA, Chino, JP, Ready, N, D'Amico, TA, Berry, MF, Sporn, T, Boyd, J, and Kelsey, CR. "Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy." J Thorac Oncol 7, no. 7 (July 2012): 1141-1147. Full Text Link to Item
  - Vlahovic, G, Meadows, KL, Uronis, HE, Morse, MA, Blobe, GC, Riedel, RF, Zafar, SY, Alvarez-Secord, A, Gockerman, J, Starodub, AN, Ready, NE, Anderson, EL, Bendell, JC, and Hurwitz, HI. "A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors." Cancer Chemother Pharmacol 70, no. 1 (July 2012): 95-102. Full Text Link to Item
  - Cuneo, KC, Zagar, TM, Brizel, DM, Yoo, DS, Hoang, JK, Chang, Z, Wang, Z, Yin, FF, Das, SK, Green, S, Ready, N, Bhatti, MT, Kaylie, DM, Becker, A, Sampson, JH, and Kirkpatrick, JP. "Stereotactic radiotherapy for malignancies involving the trigeminal and facial nerves." Technol Cancer Res Treat 11, no. 3 (June 2012): 221-228. Full Text Link to Item
  - Higgins, KA, Chino, JP, Berry, M, Ready, N, Boyd, J, Yoo, DS, and Kelsey, CR. "Local failure in resected N1 lung cancer: implications for adjuvant therapy." Int J Radiat Oncol Biol Phys 83, no. 2 (June 1, 2012): 727-733. Full Text Link to Item
  - Lee, WT, Yoo, DS, Puscas, L, Witsell, D, Cohen, SM, Fisher, SR, Scher, R, Broadwater, G, Ready, N, Brizel, DR, and Esclamado, RM. "Treatment-induced changes in vocal cord mobility and subsequent local recurrence after organ preservation therapy for laryngeal carcinoma." Head Neck 34, no. 6 (June 2012): 792-796. Full Text Link to Item
  - Yoo, DS, Kirkpatrick, JP, Craciunescu, O, Broadwater, G, Peterson, BL, Carroll, MD, Clough, R, MacFall, JR, Hoang, J, Scher, RL, Esclamado, RM, Dunphy, FR, Ready, NE, and Brizel, DM. "Prospective trial of synchronous bevacizumab, erlotinib, and concurrent chemoradiation in locally advanced head and neck cancer." Clin Cancer Res 18, no. 5 (March 1, 2012): 1404-1414. Full Text Link to Item
  - Ready, NE, Rathore, R, Johnson, TT, Nadeem, A, Chougule, P, Ruhl, C, Radie-Keane, K, Theall, K, Wanebo, HJ, Marcello, J, and Kennedy, T. "Weekly paclitaxel and carboplatin induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck." American Journal of Clinical Oncology: Cancer Clinical Trials 35, no. 1 (2012): 6-12. Full Text
  - Ready, NE, Dudek, AZ, Pang, HH, Hodgson, LD, Graziano, SL, Green, MR, and Vokes, EE. "Cisplatin, irinotecan, and bevacizumab for untreated extensive-stage small-cell lung cancer: CALGB 30306, a phase II study." J Clin Oncol 29, no. 33 (November 20, 2011): 4436-4441. Full Text Link to Item
  - Higgins, KA, Chino, JP, Ready, N, Onaitis, MW, Berry, MF, D'Amico, TA, and Kelsey, CR. "Persistent N2 disease after neoadjuvant chemotherapy for non-small-cell lung cancer." J Thorac Cardiovasc Surg 142, no. 5 (November 2011): 1175-1179. Full Text Link to Item
  - Pepek, JM, Chino, JP, Marks, LB, D'amico, TA, Yoo, DS, Onaitis, MW, Ready, NE, Hubbs, JL, Boyd, J, and Kelsey, CR. "How well does the new lung cancer staging system predict for local/regional recurrence after surgery?: A comparison of the TNM 6 and 7 systems." J Thorac Oncol 6, no. 4 (April 2011): 757-761. Full Text Link to Item
  - Ahmed, S, Birnbaum, AE, Safran, HP, Dipetrillo, TA, Aswad, BI, Ready, NE, and Ng, T. "Pathologic response after neoadjuvant carboplatin and weekly paclitaxel for early-stage lung cancer: A Brown University Oncology Group phase II study." Journal of Thoracic Oncology 6, no. 8 (2011): 1432-1434. Full Text
  - Kalemkerian, GP, Akerley, W, Rogner, P, Borghaei, H, Chow, L, Downey, RJ, Gandhi, L, Ganti, AKP, Govindan, R, Grecula, JC, Hayman, J, Heist, RS, Horn, L, Jahan, TM, Koczywas, M, Moran, CA, Niell, HD, O'Malley, J, Patel, JD, Ready, N, Rudin, CM, and Jr, CCW. "Small cell lung cancer clinical practice guidelines in oncology." JNCCN Journal of the National Comprehensive Cancer Network 9, no. 10 (2011): 1086-1113.
  - Ready, N, Karaseva, NA, Orlov, SV, Luft, AV, Popovych, O, Holmlund, JT, Wood, BA, and Leopold, L. "Double-blind, placebo-controlled, randomized phase 2 study of the proapoptotic agent AT-101 plus docetaxel, in second-line non-small cell lung cancer." Journal of Thoracic Oncology 6, no. 4 (2011): 781-785. Full Text
  - Wanebo, HJ, Rathore, R, Chougule, P, Disiena, MR, Koness, RJ, McRae, RG, Nigri, PT, Radie-Keane, K, and Ready, N. "Selective organ preservation in operable locally advanced head and neck squamous cell carcinomas guided by primary site restaging biopsy: Long-term results of two sequential brown university oncology group chemoradiotherapy studies." Annals of Surgical Oncology 18, no. 12 (2011): 3479-3485. Full Text
  - Birnbaum, A, Dipetrillo, T, Rathore, R, Anderson, E, Wanebo, H, Puthwala, Y, Joyce, D, Safran, H, Henderson, D, Kennedy, T, Ready, N, and Sio, TT-W. "Cetuximab, paclitaxel, carboplatin, and radiation for head and neck cancer: A toxicity analysis." American Journal of Clinical Oncology: Cancer Clinical Trials 33, no. 2 (2010): 144-147. Full Text
  - Rathore, R, Birnbaum, A, Rathore, B, Dipetrillo, T, Kennedy, T, and Ready, N. "Carboplatin with weekly docetaxel and ifosfamide in advanced head and neck cancers: A phase i Brown University Oncology Group dose escalation study (HN-93)." Cancer Chemotherapy and Pharmacology 66, no. 6 (2010): 1013-1017. Full Text
  - Ready, N, Jänne, PA, Bogart, J, Dipetrillo, T, Garst, J, Graziano, S, Gu, L, Wang, X, Green, MR, and Vokes, EE. "Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: Cancer and Leukemia Group B (CALEB) 30106, a CALGB-Stratified Phase II Trial." Journal of Thoracic Oncology 5, no. 9 (2010): 1382-1390. Full Text
  - Stevenson, M, Mostertz, W, Acharya, C, Kim, W, Walters, K, Barry, W, Higgins, K, Tuchman, SA, Crawford, J, Vlahovic, G, Ready, N, Onaitis, M, and Potti, A. "Characterizing the clinical relevance of an embryonic stem cell phenotype in lung adenocarcinoma." Clin Cancer Res 15, no. 24 (December 15, 2009): 7553-7561. Full Text Link to Item
  - Higgins, K, Chino, JP, Marks, LB, Ready, N, D'Amico, TA, Clough, RW, and Kelsey, CR. "Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer." Int J Radiat Oncol Biol Phys 75, no. 5 (December 1, 2009): 1462-1467. Full Text Link to Item
  - Kelsey, CR, Marks, LB, Hollis, D, Hubbs, JL, Ready, NE, D'Amico, TA, and Boyd, JA. "Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients." Cancer 115, no. 22 (November 15, 2009): 5218-5227. Full Text Link to Item
  - Hirsh, R, Giri, D, Griffith, R, Stone, R, and Ready, N. "Langerhans cell histiocytosis following acute leukemia in an adult." American Journal of Hematology 84, no. 10 (2009): 693-694. Full Text
  - Zhu, AX, Ready, N, Clark, JW, Safran, H, Amato, A, Salem, N, Pace, S, He, X, Zvereva, N, Lynch, TJ, Ryan, DP, and Supko, JG. "Phase I and Pharmacokinetic study of gimatecan given orally once a week for 3 of 4 weeks in Patients with advanced solid tumors." Clinical Cancer Research 15, no. 1 (2009): 374-381. Full Text
  - Chougule, PB, Akhtar, MS, Rathore, R, Koness, J, McRae, R, Nigri, P, Radie-Keane, K, Kennedy, T, Wanebo, HJ, and Ready, N. "Concurrent chemoradiotherapy with weekly paclitaxel and carboplatin for locally advanced head and neck cancer: Long-term follow-up of a Brown University Oncology Group phase II study (HN-53)." Head and Neck 30, no. 3 (2008): 289-296. Full Text
  - Kalemkerian, GP, Akerley, W, Downey, RJ, Ettinger, DS, Fossella, F, Grecula, JC, Jahan, T, Johnson, BE, Kessinger, A, Koczywas, M, Langer, CJ, Martins, R, Niell, HB, Pan, CC, Ramnath, N, Ready, N, Robert, F, and Jr, CCW. "Small cell lung cancer." JNCCN Journal of the National Comprehensive Cancer Network 6, no. 3 (2008): 294-314.
  - Ready, NE, Lipton, A, Zhu, Y, Statkevich, P, Frank, E, Curtis, D, and Bukowski, RM. "Phase I study of the farnesyltransferase inhibitor lonafarnib with weekly paclitaxel in patients with solid tumors." Clin Cancer Res 13, no. 2 Pt 1 (January 15, 2007): 576-583. Full Text Link to Item
  - Grieco, CA, Simon, CJ, Mayo-Smith, WW, Dipetrillo, TA, Ready, NE, and Dupuy, DE. "Image-guided percutaneous thermal ablation for the palliative treatment of chest wall masses." American Journal of Clinical Oncology: Cancer Clinical Trials 30, no. 4 (2007): 361-367. Full Text
  - Shah, C, Ready, N, Perry, M, Kirshner, J, Gajra, A, Neuman, N, and Garziano, S. "A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung cancer." Lung Cancer 57, no. 1 (2007): 84-88. Full Text
  - Akerley, W, Safran, H, Zaner, K, Ready, N, Mega, T, and Kennedy, T. "Phase II trial of weekly paclitaxel and gemcitabine for previously untreated, Stage IIIB-IV nonsmall cell lung cancer." Cancer 107, no. 5 (2006): 1050-1054. Full Text
  - Dupuy, DE, DiPetrillo, T, Gandhi, S, Ready, N, Ng, T, Donat, W, and Mayo-Smith, WW. "Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer." Chest 129, no. 3 (2006): 738-745. Full Text
  - Grieco, CA, Simon, CJ, Mayo-Smith, WW, DiPetrillo, TA, Ready, NE, and Dupuy, DE. "Percutaneous image-guided thermal ablation and radiation therapy: Outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer." Journal of Vascular and Interventional Radiology 17, no. 7 (2006): 1117-1124. Full Text
  - Birnbaum, A, and Ready, N. "Gefitinib therapy for non-small cell lung cancer." Current Treatment Options in Oncology 6, no. 1 (2005): 75-81.
  - Ready, N, Aronson, F, Wanebo, H, and Kennedy, T. "A low rate of central nervous system progression in a phase II trial of outpatient chemobiologic therapy with cisplatin, temozolomide, interleukin-2, and interferon alfa 2-B for metastatic malignant melanoma." American Journal of Clinical Oncology: Cancer Clinical Trials 28, no. 5 (2005): 479-484. Full Text
  - Ready, N. "Inhibition of the epidermal growth factor receptor in combined modality treatment for locally advanced non-small cell lung cancer." Seminars in Oncology 32, no. SUPPL. 3 (2005): S35-S41. Full Text
  - Cox, JD, Chevalier, TL, Arriagada, R, Choy, H, Curran, WJ, Fukuoka, M, Harper, P, Komaki, R, Pechoux, CL, Lievens, Y, Rami-Porta, R, Ready, N, Sause, W, Stuschke, M, and Thatcher, N. "Management of unresectable non-small cell carcinoma of the lung (NSCLC)." Lung Cancer 42, no. 2 SUPPL. (2003): S15-S16. Full Text
  - Postmus, PE, Rocmans, P, Asamura, H, Ball, D, Belderbos, J, Cappello, M, Jassem, J, Novello, S, Pass, H, Passlick, B, Pirker, R, Ready, N, Sause, W, Scagliotti, G, Vansteenkiste, J, Westeel, V, and Zandwijk, NV. "Consensus report IASLC workshop Bruges, September 2002: Pretreatment minimal staging for non-small cell lung cancer." Lung Cancer 42, no. 2 SUPPL. (2003): S3-S6. Full Text
  - Ready, N, and Weinstock, MA. "Elective lymph node dissection for melanoma laid to rest yet again." Archives of Dermatology 139, no. 9 (2003): 1203-1204. Full Text
  - Ready, N, and Weinstock, MA. "Adjuvant High-Dose Interferon Therapy for High-Risk Melanoma." Archives of Dermatology 139, no. 12 (2003): 1635-1637. Full Text
  - Ready, NE, and Vokes, EE. "Induction or consolidation systemic therapy in the multimodality treatment of unresectable locally advanced non-small cell lung cancer." Lung Cancer 42, no. 2 SUPPL. (2003): S65-S69. Full Text
  - Akerley, W, Rathore, R, Ready, N, Leone, L, Sikov, W, Safran, H, and Kennedy, T. "A phase I study of a weekly schedule of paclitaxel and carboplatin in patients with advanced carcinoma." Cancer 95, no. 9 (2002): 2000-2005. Full Text
  - Moore, T, and Ready, N. "Update in non-small cell lung cancer." Medicine and health, Rhode Island 85, no. 1 (2002): 7-9.
  - Wanebo, H, Chougule, P, Ready, N, Safran, H, Ackerley, W, Koness, RJ, McRae, R, Nigri, P, Leone, L, Radie-Keane, K, Reiss, P, and Kennedy, T. "Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV)." Annals of Surgical Oncology 8, no. 8 (2001): 644-650. Full Text
  - Chougule, PB, Akhtar, MS, Akerley, W, Ready, N, Safran, H, McRae, R, Nigri, P, Bellino, J, Koness, J, Radie-Keane, K, and Wanebo, H. "Chemoradiotherapy for advanced inoperable head and neck cancer: A phase II study." Seminars in Radiation Oncology 9, no. 2 SUPPL. 1 (1999): 58-63.
  - Wanebo, HJ, Chougule, P, Ready, N, Koness, RJ, Akerley, W, McRae, R, Nigri, P, Leone, L, Webber, B, and Safran, H. "Preoperative paclitaxel, carboplatin, and radiation therapy in advanced head and neck cancer (stage III and IV)." Seminars in Radiation Oncology 9, no. 2 SUPPL. 1 (1999): 77-84.
  - Kluger, NJ, Cummings, FJ, Ready, NE, Sweeney, JD, and Weitberg, AB. "Post transfusion non-cardiogenic pulmonary edema in a patient with chemotherapy-related hemolytic uremic syndrome." Medicine and health, Rhode Island 81, no. 7 (1998): 235-236.
  - Chougule, P, Wanebo, H, Akerley, W, McRae, R, Nigri, P, Leone, L, Safran, H, Ready, N, Koness, RJ, Radie-Keane, K, and Cole, B. "Concurrent paclitaxel, carboplatin, and radiotherapy in advanced head and neck cancers: A phase II study - Preliminary results." Seminars in Oncology 24, no. 6 SUPPL. 19 (1997): S19-57-S19-61-.
  - Wanebo, HJ, Chougule, P, III, WLA, Koness, RJ, McRae, R, Nigri, P, Leone, L, Ready, N, Safran, H, Webber, B, and Cole, B. "Preoperative chemoradiation coupled with aggressive resection as needed ensures near total control in advanced head and neck cancer." American Journal of Surgery 174, no. 5 (1997): 518-522. Full Text
  - Celi, A, Pellegrini, G, Lorenzet, R, Blasi, AD, Ready, N, Furie, BC, and Furie, B. "P-selectin induces the expression of tissue factor on monocytes." Proceedings of the National Academy of Sciences of the United States of America 91, no. 19 (1994): 8767-8771. Full Text
  - Ready, N, Freeman, NJ, and Carvalho, A. "Treatment choices in chronic myelogenous leukemia." Hospital Practice 27, no. 9 A (1992): 95-98+101.
  - Mizisin, AP, and Ready, NE. "Growth and development of flight muscle in the locust (Schistocerca nitens, Thunberg)." Journal of Experimental Zoology 237, no. 1 (1986): 45-55.
  - Ready, NE. "Development of fast singing muscles in a katydid." The Journal of experimental zoology 238, no. 1 (1986): 43-54.
  - Ready, NE, and Najm, RE. "Structural and functional development of cricket wing muscles." Journal of Experimental Zoology 233, no. 1 (1985): 3550--.
  - Ready, NE, and Najm, RE. "Structural and functional development of cricket ring muscles." Journal of Experimental Zoology 233, no. 1 (1985): 35-50.
  - Ready, NE, and Josephson, RK. "Flight muscle development in a hemimetabolous insect." Journal of Experimental Zoology 220, no. 1 (March 1, 1982): 49-56. Full Text
  - Oglesby, LC, Mangum, CP, Heacox, AE, and Ready, NE. "Salt and water balance in the polychaete Nereis virens." Comparative Biochemistry and Physiology -- Part A: Physiology 73, no. 1 (1982): 15-19.
- Other Articles
  - Stevenson, M, Mostertz, W, Acharya, CR, Kim, W, Walters, K, Barry, W, Higgins, K, Tuchman, SA, Crawford, J, Vlahovic, G, Ready, N, Onaitis, M, and Potti, A. "Retraction: characterizing the clinical relevance of an embryonic stem cell phenotype in lung adenocarcinoma." Clin Cancer Res 18, no. 6 (March 15, 2012): 1818-. Full Text Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

Selected Grants

Selected Publications

Journal Articles

Other Articles